
Palborest 100mg Tablet
Marketer
MSN Laboratories
Salt Composition
Palbociclib (100mg)
Overview Palborest 100mg Tablet
Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with Palborest 100mg tablets, administered concurrently with hormonal anticancer therapies. For optimal absorption, consume this medication with food at the same time daily, as prescribed by your physician. Dosage and frequency are individualized and subject to change based on your response to treatment. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. While therapeutic benefits may not be immediately apparent (weeks or months), discontinue use only under your doctor's guidance. Common side effects include nausea, hair loss, skin reactions, and gastrointestinal upset. Palborest can decrease blood cell counts, increasing infection risk; report any fever, chills, unusual bleeding, or bruising to your physician. Dizziness is a potential side effect; refrain from driving or hazardous activities if affected. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including those for infections, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout the treatment period.
Uses of Palborest 100mg Tablet
Malignant breast tumor
Major Benefits of Palborest 100mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 100mg Palborest tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Palborest 100mg Tablet:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Palborest 100mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take the Palborest 100mg Tablet with a meal.
How Palborest 100mg Tablet works:
Palborest 100mg tablets function as an anti-cancer agent. Its mechanism involves blocking cyclin-dependent kinases 4 and 6, crucial proteins driving cell growth and proliferation via downstream signaling pathways. This blockade halts the cancerous cell cycle's progression. Furthermore, it specifically targets estrogen receptor-positive breast cancers by interfering with cellular replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Palborest 100mg Tablet and alcohol is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Palborest 100mg tablets during pregnancy poses a known risk to the unborn child. Therefore, its use is discouraged. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the inherent dangers. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Palborest 100mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Palborest 100mg Tablets, as they can induce fatigue in certain individuals. Operate machinery or vehicles with care if experiencing this effect.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Palborest 100mg tablets are considered safe and do not require a dosage alteration.
LiverCAUTION
Patients with liver impairment should use Palborest 100mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Palborest 100mg Tablet :
NA
Facts to Know About Palborest 100mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | CDK Inhibitor |
